ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared USA

Arbutus Biopharma Corporation Complete list of announcements declared & dividend announcements by Arbutus Biopharma Corporation ABUS

Arbutus Biopharma Corporation ABUS listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Arbutus Biopharma Corporation ABUS

Arbutus Biopharma Reacquires Rights to Imdusiran in Greater China, Concludes Partnership with Qilu Pharmaceutical
Arbutus reclaims rights to imdusiran in Greater China and establishes a new Scientific Advisory Board for chronic HBV treatment.
Announcement as on 25 June 2025

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
Arbutus Biopharma (ABUS) came out with a quarterly loss of [CO].10 per share in line with the Zacks Consensus Estimate. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 06 November 2024

Arbutus Biopharma (ABUS) Reports Q3 Loss, Lags Revenue Estimates
Arbutus Biopharma (ABUS) came out with a quarterly loss of [CO].10 per share in line with the Zacks Consensus Estimate. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 06 November 2024

Arbutus Biopharma Reports Claim Construction Ruling In Patent Infringement Lawsuit Against Moderna
(RTTNews) - Arbutus Biopharma (ABUS) issued statement regarding the claim construction ruling of the U.S. District Court for the District of Delaware in the lawsuit brought by Arbutus and its licensee Genevant Sciences against Moderna seeking damages for i
Announcement as on 04 April 2024

Announcements by Arbutus Biopharma Corporation first page |

ABUS Arbutus Biopharma Corporation current price & indicator signals

Moving Averages for Arbutus Biopharma Corporation

  • 5Day Average: 4.33
  • 12Day Average: 4.32
  • 20Day Average: 4.43
  • 50Day Average: 4.44
  • 100Day Average: 4.09
  • 150Day Average: 3.83
  • 200Day Average: 3.7

ABUS Indicators & signals

Indicator MACD (12,26,9)

4.37, 4.41, -0.04
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 33.33, 29.17
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ABUS Arbutus Biopharma Corporation are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 4.42 4.31 to 4.45 0.23% 0.75 times
04 Thu Dec 2025 4.41 4.31 to 4.64 -0.45% 0.52 times
03 Wed Dec 2025 4.43 4.11 to 4.45 6.24% 2.05 times
02 Tue Dec 2025 4.17 4.09 to 4.26 -0.95% 0.94 times
01 Mon Dec 2025 4.21 4.19 to 4.35 -4.54% 0.79 times
28 Fri Nov 2025 4.41 4.37 to 4.46 0% 0.41 times
26 Wed Nov 2025 4.41 4.25 to 4.43 2.08% 0.92 times
25 Tue Nov 2025 4.32 4.23 to 4.41 1.17% 0.57 times
24 Mon Nov 2025 4.27 4.18 to 4.42 -0.93% 1.54 times
21 Fri Nov 2025 4.31 4.16 to 4.37 2.62% 0.82 times
20 Thu Nov 2025 4.20 4.08 to 4.35 -1.64% 1.45 times
19 Wed Nov 2025 4.27 4.26 to 4.47 -4.04% 2.91 times

Videos related to: ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

ABUS announcements Arbutus Biopharma Corporation announcements and dividends declared USA

 

Back to top